Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigating SNF2 Histone Linker PHD RING Helicase as a Risk Factor for Lung Cancer Initiation and Development

EF 2022-23

Résumé
Lung cancer causes 1.8 million deaths a year, making it the deadliest cancer in the world. One major reason is that people often find out about their disease too late, when it has already begun to spread throughout the body. At this stage, treatment options are limited and ineffective, leading to more deaths. As such, it is important to be able to find and treat lung cancer earlier. One way to do so would be to identify the people most at risk of developing lung cancer. Smoking is the main cause of lung cancer. However, not all smokers will develop lung cancer, and people who never smoke can also get it. This suggests that other factors such as genetics may also affect lung cancer risk. A gene that interests our lab is SHPRH as our previous work in our lab has shown it is often missing in people with lung cancer, whereas the presence of this gene may help prevent lung cancer. We now aim to study whether SHPRH is associated with risk of developing lung cancer. To do this, we will first assess if SHPRH can prevent lung cancer, and what would happen if people lacking this gene were exposed to cancer causing materials such as cigarette smoke. We believe that SHPRH makes cells more resilient, and when it is missing, cells are more easily damaged by cancer-causing materials, which eventually leads to cancer. This research can help identify patients who may be more at risk for developing lung cancer and help develop more specific treatments for these patients. As well, understanding the potential effect of cancer-causing materials on patients without SHPRH can influence lung cancer prevention strategies. Hopefully, this will be able to help increase the treatment options and survival of those affected by this devastating disease.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486614
Name
Chuang Yu-Chi (Serena)
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating SNF2 Histone Linker PHD RING Helicase as a Risk Factor for Lung Cancer Initiation and Development
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Carcinogens; Environmental Pollution; Genetic Alterations; Genetic Susceptibility; Lung Cancer; Protein Interactions; Risk Factors; Smoking; Tumorigenesis; Tumour Suppressor
Abstract
Lung cancer causes 1.8 million deaths a year, making it the deadliest cancer in the world. One major reason is that people often find out about their disease too late, when it has already begun to spread throughout the body. At this stage, treatment options are limited and ineffective, leading to more deaths. As such, it is important to be able to find and treat lung cancer earlier. One way to do so would be to identify the people most at risk of developing lung cancer. Smoking is the main cause of lung cancer. However, not all smokers will develop lung cancer, and people who never smoke can also get it. This suggests that other factors such as genetics may also affect lung cancer risk. A gene that interests our lab is SHPRH as our previous work in our lab has shown it is often missing in people with lung cancer, whereas the presence of this gene may help prevent lung cancer. We now aim to study whether SHPRH is associated with risk of developing lung cancer. To do this, we will first assess if SHPRH can prevent lung cancer, and what would happen if people lacking this gene were exposed to cancer causing materials such as cigarette smoke. We believe that SHPRH makes cells more resilient, and when it is missing, cells are more easily damaged by cancer-causing materials, which eventually leads to cancer. This research can help identify patients who may be more at risk for developing lung cancer and help develop more specific treatments for these patients. As well, understanding the potential effect of cancer-causing materials on patients without SHPRH can influence lung cancer prevention strategies. Hopefully, this will be able to help increase the treatment options and survival of those affected by this devastating disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chuang, Yu-Chi (Serena)
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~